MBTPS1 and cancer: Interestingly, the anti-cancer activity of an anti-S1P monoclonal antibody (sphingomabTM) [29], which neutralizes S1P and inhibits its extracellular signaling, provides evidence of the importance of exogenous S1P in mediating tumor growth and metastatic potential [23, 30, 31].